What Patients Need to Know

About the Inflation Reduction Act’s Healthcare Provisions

How Price Control Hurts Patients

Enacted in 2022, the Inflation Reduction Act(IRA) jeopardizes drug development and patient access to critical treatments, notably through its Medicare “price negotiation” provision, which is effectively government price control. Europe’s experience with similar policies led to a collapse in drug development and worse health outcomes significantly higher cancer mortality rates. Consequently, numerous patient advocacy groups are opposing their implementation in the U.S.

400,000 more deaths each year

If U.S. cancer patients had European cancer death rates

60% of new drugs

are developed in the U.S.

90% of new medicines

are available to U.S. patients within the first year of launch

Op-Ed

Medicare Price Controls Blow Up Biden’s ‘Cancer Moonshot’ on Launch Pad

By Michael Reilly

In February, President Biden relaunched the “Cancer Moonshot” program first begun during his vice presidency in 2016. He has now set an ambitious national goal: cutting the death rate from cancer by at least 50% over the next 25 years. A laudable goal, but unfortunately, another recent policy from his administration threatens to blow up his Cancer Moonshot while still on the launchpad.

impact of the inflation reduction act (IRA)

“Instead of cancer patients gaining increased access to the latest cancer drugs, they may soon wait years longer for a life-saving drug to reach their hands, if it comes at all.”

More articles

ASBM’s Comments on the Medicare Drug Price Negotiation Plan: Protecting Patients and Ensuring Access to Medicines…

In the NEws

Amend law to combat skyrocketing colorectal cancer rates (opinion)

Drug-pricing rules in Inflation Reduction Act will stymie efforts to develop new treatments.

Reading Eagle | Andrew Spiegel

Mitigating the Inflation Reduction Act’s Adverse Impacts on the Prescription Drug Market

The purported goal of the Inflation Reduction Act (IRA) of 2022 is to lower healthcare costs for Americans.

USC Schaeffer | Dana Goldman, PhD, Joseph Grogan, JD,Darius Lakdawalla, PhD,Barry Liden, JD,Jason Shafrin, PhD,Kyi-Sin Than, MPHandErin Trish, PhD

The Ultimate Price Of Government Price Controls

Democrats have nudged the U.S. healthcare system closer to Canadian-style socialism with their recently signed, and dubiously named, Inflation Reduction Act.

Forbes | Sally Pipes

Resources

Learn more about IRA price controls and spread the word with these materials from ABSM.

Media

Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae; Donec velit neque, auctor sit amet aliquam vel, ullamcorper sit amet ligula.